Nilotinib-Chemotherapy in CML Myeloid BP or Bcr-abl(+) AML; NICE-BORA

Press/Media: Press / Media

Period2018 Oct 2

Media coverage

1

Media coverage

  • TitleNilotinib-Chemotherapy in CML Myeloid BP or Bcr-abl(+) AML; NICE-BORA
    Media name/outletClinical Trials.gov
    Country/TerritoryUnited States
    Date18/10/2
    Personsminjung Kim